A Prospective Study to Assess the Utility of CA-4F in a Canadian Cardiology Setting
Not Applicable
- Conditions
- Transthyretin Amyloid Cardiomyopathy ("ATTR-CM")
- Interventions
- Device: CA-4F
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2022-01-27
- Lead Sponsor
- Ensho Health Intelligent Systems Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT05210010
- Locations
- π¨π¦
Site 85237, North Vancouver, British Columbia, Canada
π¨π¦Site 26174, Oakville, Ontario, Canada
π¨π¦Site 47844, Scarborough, Ontario, Canada
Β© Copyright 2025. All Rights Reserved by MedPath